Iran’s vaccine safe, effective against coronavirus: Studies
The second phase of the human trial for Iran's Coviran vaccine suggests it is safe and provides effective immunity against the coronavirus.
Produced by the headquarters for the Execution of Imam Khomeini's Order, Coviran was injected to 280 volunteers in the second clinical stage and the results were reported to the Health Ministry accordingly.
Once the second phase is over and the vaccine is proved effective against the coronavirus, the third and final stage will then be initiated, which involves giving the jabs to 20,000 volunteers.
Coviran authorities say they have already issued the call for voluntary injections, since time is running short.
The first phase of the clinical trial was carried out in December last year, which proved that the vaccine is safe and will not cause any side effects.
Other than Coviran, Iran is working on seven other homegrown vaccines, including COV-PARS, which is now undergoing the first phase of the human trials.
This is as the country has already started mass vaccination, mainly using Russia's Sputnik V.
Coviran is already ahead in the race compared to other Iranian-made vaccines. Now as the fourth surge in the pandemic is sweeping the country, Coviran developers say they are doing their utmost to bring vaccine doses to the market in the next two months.